Free Trial

Reckitt Benckiser Group (OTCMKTS:RBGLY) Sets New 52-Week High - Should You Buy?

Reckitt Benckiser Group logo with Consumer Staples background

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) shares reached a new 52-week high during trading on Thursday . The company traded as high as $15.14 and last traded at $15.07, with a volume of 140203 shares traded. The stock had previously closed at $13.86.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein raised Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Two investment analysts have rated the stock with a hold rating, two have given a buy rating and four have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Buy".

Read Our Latest Analysis on RBGLY

Reckitt Benckiser Group Stock Up 8.8%

The firm has a 50 day moving average price of $13.67 and a 200-day moving average price of $13.24. The company has a debt-to-equity ratio of 1.08, a quick ratio of 0.39 and a current ratio of 0.58.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines